Cell2in

Seoul, South Korea Founded: 2016 • Age: 10 yrs
Probes and oligos are developed for molecular biology research.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Cell2in

Cell2in is a company based in Seoul (South Korea) founded in 2016. Cell2in operates in a competitive market with competitors including NuProbe, Nanosphere, ATDBio, Marker Gene Technologies and SciGenom, among others.

  • Headquarter Seoul, South Korea
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Cell2in

Premium access

Detailed funding history for Cell2in

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cell2in

Investments
Premium access

Investment portfolio details for Cell2in

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cell2in

Premium access

Detailed financials for Cell2in

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cell2in Comparisons

Cell2in Primary company
Description
Probes and oligos are developed for molecular biology resear...
Location
Seoul, South Korea
Founded Year
2016
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Cell2in

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cell2in

Cell2in operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Nanosphere, ATDBio, Marker Gene Technologies and SciGenom, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Sensitive multiplex platforms for QPCR are developed using toehold probes.
Locked Locked Locked
Diagnostic tests for personalized medicine targeting infections are provided.
Locked Locked Locked
Developer of oligonucleotides
Locked Locked Locked
Develops kits and reagents for research application
Locked Locked Locked
Provider of genome sequencing and bioinformatics services life science and healthcare sector
Locked Locked Locked
Non-enzymatic nucleic acid detection technology is developed using DGL probes.
Premium access

Detailed competitors of Cell2in

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cell2in

Premium access

Complete news archive for Cell2in

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cell2in

Cell2in was founded in 2016.

Cell2in is headquartered in Seoul, South Korea.

Heun Soo Kang is the current CEO of Cell2in.

Cell2in was founded in 2016 in Seoul, South Korea, within the biotechnology sector. Probes and oligonucleotides are developed for molecular biology applications. FreSHtracer, a fluorescent dye, is provided to assess glutathione levels in living cells, enabling penetration into cellular components. Services encompass cell therapy support, stem cell quality control, cell culture media evaluation, and antioxidant screening processes.

Cell2in's top competitors include NuProbe, Nanosphere and SciGenom.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available